Cannabinoids have established themselves as therapeutic options in the treatment of pain in recent years. Nevertheless, patients can experience problems when using them, particularly with regard to tolerance. A new aqueous nanodispersion appears to be able to eliminate these problems.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
Related Topics
You May Also Like
- Cervical Cancer
HPV prevention, screening innovation and sentinel lymph node biopsy
- Polypharmacy: use of eHealth tools in Switzerland
Survey study in primary care
- From symptom to diagnosis
Abdominal pain – Prostate abscess
- Asthma during pregnancy
Up to 40% suffer worsening of symptoms during pregnancy
- From symptom to diagnosis
Complicated renal cysts
- Atrial fibrillation
Anticoagulation after catheter ablation – for how long?
- Wound treatment and dermal defect coverage
Fish skin matrix for the treatment of complex ulcers
- Well-being of the medical profession in primary care